Supplemental Table S4 shows the top five most influential inputs based on the one-way sensitivity analyses on each of the mean change in costs, QALYs, and life-years with the addition of DS reflex to common co-testing screening strategies</p
<p>Strategies standing on the curve are dominant strategies, indicating that they cost less and had ...
In 2012, clinical guidelines for cervical cancer screening developed by a coalition of experts from ...
Importance: Evidence on the relative benefits and harms of primary high-risk human papillomavirus (h...
Supplemental Figure S1 shows tornado diagrams of range of results observed in the one-way sensitivit...
Supplemental Table S1 shows the unpublished data from the IMPACT clinical trial referenced in for th...
Supplemental Table S3 shows the procedure codes, CMS fee schedule payments, and usage information us...
Supplemental Table S2 shows the distribution of patient attributes in the prevalent US population of...
Supplemental Figure S2 shows the proportion of the PSA simulations that were cost-effective at varyi...
Objectives: The aim of this study was to evaluate the cost-effectiveness of cervical cancer screenin...
ImportanceMany cervical cancer screening strategies are now recommended in the United States, but th...
Because cost-effectiveness of different cervical cytology screening strategies with and without huma...
BACKGROUND:HPV test appears to be more effective in cervical cancer (CC) screening. However, the dec...
Objective To determine the most cost-effective screening programme for cervical cancer. Design Cost-...
Background: In the UK more than 3 million women are screened each year as part of a national screeni...
Human papillomavirus (HPV) partial genotyping (PGT) identifies HPV16 and HPV18 individually, alongsi...
<p>Strategies standing on the curve are dominant strategies, indicating that they cost less and had ...
In 2012, clinical guidelines for cervical cancer screening developed by a coalition of experts from ...
Importance: Evidence on the relative benefits and harms of primary high-risk human papillomavirus (h...
Supplemental Figure S1 shows tornado diagrams of range of results observed in the one-way sensitivit...
Supplemental Table S1 shows the unpublished data from the IMPACT clinical trial referenced in for th...
Supplemental Table S3 shows the procedure codes, CMS fee schedule payments, and usage information us...
Supplemental Table S2 shows the distribution of patient attributes in the prevalent US population of...
Supplemental Figure S2 shows the proportion of the PSA simulations that were cost-effective at varyi...
Objectives: The aim of this study was to evaluate the cost-effectiveness of cervical cancer screenin...
ImportanceMany cervical cancer screening strategies are now recommended in the United States, but th...
Because cost-effectiveness of different cervical cytology screening strategies with and without huma...
BACKGROUND:HPV test appears to be more effective in cervical cancer (CC) screening. However, the dec...
Objective To determine the most cost-effective screening programme for cervical cancer. Design Cost-...
Background: In the UK more than 3 million women are screened each year as part of a national screeni...
Human papillomavirus (HPV) partial genotyping (PGT) identifies HPV16 and HPV18 individually, alongsi...
<p>Strategies standing on the curve are dominant strategies, indicating that they cost less and had ...
In 2012, clinical guidelines for cervical cancer screening developed by a coalition of experts from ...
Importance: Evidence on the relative benefits and harms of primary high-risk human papillomavirus (h...